Sar-Arg-Val-Tyr-Ile-His-Pro-Phe begins with sarcosine, introducing N-methylation that affects backbone flexibility and enzyme recognition. The remaining residues provide a balance of hydrophobic, aromatic, and basic functionalities. Researchers employ the sequence to model receptor-binding epitopes and peptide-protein contacts. Applications include ligand-optimization projects, signaling-pathway analysis, and structure-activity investigations.
CAT No: R2709
CAS No:102029-89-0
Synonyms/Alias:Sar-Arg-Val-Tyr-Ile-His-Pro-Phe;102029-89-0;N-Methylglycyl-N~5~-(diaminomethylidene)ornithylvalyltyrosylisoleucylhistidylprolylphenylalanine--acetic acid (1/1);acetic acid;2-[[1-[2-[[2-[[2-[[2-[[5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid;VIPLPZKDKSDVMT-UHFFFAOYSA-N;PAN-3948-PI;DTXSID50657523;H-Sar-Arg-Val-Tyr-Ile-His-Pro-Phe-OH;
1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.